Atomwise Company
Atomwise uses artificial intelligence for drug discovery. We design new molecules for the hardest targets. Our discoveries help our partners deliver better medicines faster.
Investors
Connections from
Total Funding:
176645000.0
Headquarters:
United
Funding Status:
Early Stage Venture
Employee Number:
94
Estimated Revenue:
2.3
Last Funding Type:
Grant
Technology:
['BioTech & HealthTech']
Investor Type:
For Profit
Last Funding Date:
2020-10-06
Investors Number:
22.0
Founded Date:
2012-01-01
Industry:
Application Software